Get the Stockscreener App
2.13
1.39%
-0.03
After Hours:
2.17
0.04
+1.88%
Nautilus Biotechnology Inc stock is traded at $2.13, with a volume of 139.92K.
It is down -1.39% in the last 24 hours and up +7.04% over the past month.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
See More
Previous Close:
$2.16
Open:
$2.14
24h Volume:
139.92K
Relative Volume:
0.55
Market Cap:
$269.03M
Revenue:
-
Net Income/Loss:
$-70.78M
P/E Ratio:
-3.8036
EPS:
-0.56
Net Cash Flow:
$-61.27M
1W Performance:
+5.45%
1M Performance:
+7.04%
6M Performance:
+198.78%
1Y Performance:
+33.12%
1-Day Range:
$2.02
$2.19
1-Week Range:
$1.97
$2.20
52-Week Range:
$0.62
$2.54
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Name
Nautilus Biotechnology Inc
Sector
Industry
Phone
206-333-2001
Address
2701 EASTLAKE AVE EAST, SEATTLE
Compare NAUT vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
2.13 | 272.82M | 0 | -70.78M | -61.27M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-24 | Downgrade | Goldman | Neutral → Sell |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-06-22 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-02-21 | Initiated | Cowen | Outperform |
| Aug-04-21 | Initiated | Goldman | Neutral |
| Jul-13-21 | Initiated | Jefferies | Buy |
View All
Nautilus Biotechnology Inc Stock (NAUT) Latest News
3 Penny Stocks With Market Caps Over $50M To Watch - simplywall.st
Earnings Miss: Does Nautilus Biotechnology Inc have strong fundamentalsStop Loss & Real-Time Buy Signal Notifications - baoquankhu1.vn
Nautilus Biotechnology explores multiomics to mitigate space travel effects - Traders Union
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - The Manila Times
Risk Hedge: Is GP Act III Acquisition Corp Equity Warrant stock suitable for long term investing - baoquankhu1.vn
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Short Interest Update - MarketBeat
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with the Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson's Disease - marketscreener.com
Nautilus Biotechnology announces research collab with WCM-Q, MJFF - TipRanks
Nautilus Biotechnology and Weill Cornell Medicine-Qatar - GlobeNewswire
Nautilus Biotechnology Insider Confidence Rewarded, Stock Hits US$275m Market Cap - 富途牛牛
What’s the MACD signal for Nautilus Biotechnology Inc.Earnings Recap Report & AI Enhanced Trading Signals - mfd.ru
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 6.3%What's Next? - MarketBeat
Analyzing Nautilus Biotechnology (NASDAQ:NAUT) and OnKure Therapeutics (NASDAQ:OKUR) - Defense World
Buyout Rumor: Why is US GoldMining Inc stock going downJuly 2025 EndofMonth & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Analyst Upgrade: Is Nautilus Biotechnology Inc stock a smart retirement pickMarket Trend Report & Risk Controlled Daily Plans - baoquankhu1.vn
Published on: 2026-01-14 06:58:20 - baoquankhu1.vn
Nautilus Biotechnology launches Iterative Mapping Early Access Program - Traders Union
Why Nautilus Biotechnology Inc. stock could rally in 2025GDP Growth & Free Safe Capital Growth Stock Tips - Улправда
Will Nautilus Biotechnology Inc. stock deliver consistent dividendsWeekly Profit Report & Risk Controlled Swing Alerts - Улправда
Why analysts upgrade Nautilus Biotechnology Inc. stock2025 Earnings Surprises & Risk Adjusted Buy and Sell Alerts - Улправда
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay - MarketScreener
Nautilus Biotechnology Launches Early Access Program for - GlobeNewswire
Nautilus Biotechnology Insiders May Regret Not Buying More, Market Cap Hits US$236m - simplywall.st
3 Penny Stocks With Market Caps Under $700M - simplywall.st
Will Nautilus Biotechnology Inc. stock outperform tech sector in 20252026 world cup usa national team qualification defensive leaders set piece tactics group prediction preview - ulpravda.ru
Corient Private Wealth LLC Acquires 390,000 Shares of Nautilus Biotechnology, Inc. $NAUT - Defense World
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) boasts of bullish insider sentiment with 33% ownership and they have been buying lately - Yahoo Finance
Nautilus Biotechnology Faces Nasdaq Delisting Risk Amid Compliance Challenges - MSN
Aug Fed Impact: Is Nautilus Biotechnology Inc stock attractive for income investorsJuly 2025 PostEarnings & Fast Gain Swing Trade Alerts - moha.gov.vn
How buybacks impact Nautilus Biotechnology Inc. stock valueJuly 2025 Trends & Verified Swing Trading Watchlists - Улправда
Will Nautilus Biotechnology Inc. stock attract more institutional investors - Улправда
Published on: 2025-12-20 14:57:12 - moha.gov.vn
Nautilus Biotechnology Earnings Notes - Trefis
Why Nautilus Biotechnology Inc. stock remains on buy lists2025 Market WrapUp & Community Consensus Picks - bolumsonucanavari.com
Is Nautilus Biotechnology Inc. stock a safe buy before earnings2025 Analyst Calls & Long-Term Growth Stock Strategies - DonanımHaber
ETF Watch: Is Nautilus Biotechnology Inc. stock a safe buy before earningsJuly 2025 Retail & Step-by-Step Trade Execution Guides - DonanımHaber
Is Nautilus Biotechnology Inc. stock supported by strong fundamentalsJuly 2025 Highlights & Verified Swing Trading Watchlist - Улправда
Is Nautilus Biotechnology Inc. stock a buy before product launches2025 Volatility Report & Capital Efficiency Focused Ideas - Улправда
Nautilus Biotechnology drives innovation in proteomics space - Traders Union
Nautilus Biotechnology (NAUT) Stock Analysis Report | Financials & Insights - Benzinga
Nautilus Biotechnology: Divergent Signals from Investors and Analysts - AD HOC NEWS
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 0.5%Here's What Happened - MarketBeat
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 0.5% – Here’s What Happened - Defense World
Is Nautilus Biotechnology Inc a good long term investmentEconomic Indicators Overview & Small Budget Portfolio Growth - earlytimes.in
Penny Stocks To Consider In December 2025 - simplywall.st
Investment Report: Will Nautilus Biotechnology Inc. stock attract more institutional investorsEarnings Growth Report & Technical Buy Zone Confirmations - moha.gov.vn
Adversity is less terrifying than hope: Nautilus Biotechnology Inc (NAUT) - setenews.com
Advancing next-generation proteomics with single-molecule Iterative Mapping - SelectScience
There is no way Nautilus Biotechnology Inc (NAUT) can keep these numbers up - Setenews
Advanced analytics toolkit walkthrough for Nautilus Biotechnology Inc.2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
What dividend safety score for Nautilus Biotechnology Inc. stockMarket Growth Report & Low Volatility Stock Recommendations - newser.com
Nautilus Biotechnology Inc Stock (NAUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):